Entering text into the input field will update the search result below

OptiNose's (OPTN) CEO Peter Miller on Q4 2020 Results - Earnings Call Transcript

Mar. 03, 2021 3:27 PM ETOptiNose, Inc. (OPTN)
SA Transcripts profile picture
SA Transcripts

OptiNose, Inc. (NASDAQ:OPTN) Q4 2020 Earnings Conference Call March 3, 2021 8:00 AM ET

Company Participants

Jonathan Neely – Vice President-Investor Relations

Peter Miller – Chief Executive Officer

Keith Goldan – Chief Financial Officer

Ramy Mahmoud – President and Chief Operating Officer

Vic Clavelli – Chief Commercial Officer

Conference Call Participants

Steve Daddeo – RBC Capital Markets

Gary Nachman – BMO Capital Markets

Brandon Folkes – Cantor Fitzgerald

David Amsellem – Piper Sandler

Georgi Yordanov – Cowen and Company

David Steinberg – Jefferies


Ladies and gentlemen, thank you for standing by and welcome to the OptiNose’s Q4 2020 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions]

I would now like to hand the call over to Jonathan Neely, Vice President of Investor Relations. Please go ahead.

Jonathan Neely

Good morning, and thank you for joining us today as we review OptiNose’s fourth quarter and full-year 2020 performance, and our plans for the remainder of the year ahead. I’m joined today by our CEO, Peter Miller; our President and Chief Operating Officer, Ramy Mahmoud; our Chief Commercial Officer, Vic Clavelli; our CFO, Keith Goldan. The slides that will be presented on this call can be viewed on our website, optinose.com in the Investors section.

Before we start, I would like to remind you that our discussions during this conference call will include forward-looking statements. All statements that are not historical facts are hereby identified as forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those indicated by such statements. Additional information regarding these factors and forward-looking statements is discussed under the cautionary note on Forward-Looking Statements section and the Risk Factors section and elsewhere in OptiNose’s Form 10-K that was filed today with the SEC and available at

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.